DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Fox E, Mayer L, Sullivan H et al.
Two-year results with alemtuzumab in patients with active relapsing-remitting multiple sclerosis who have failed licensed beta interferon therapies.
Multiple Sclerosis 2007;
13 (Suppl. 02) S166-167
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.